Suppr超能文献

诊断为远端弓部和降胸主动脉瘤的女性的不平等现象:来自有效治疗胸主动脉瘤(ETTAA)队列研究的结果。

Inequalities for women diagnosed with distal arch and descending thoracic aortic aneurysms: results from the Effective Treatments for Thoracic Aortic Aneurysms (ETTAA) cohort study.

机构信息

Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK.

Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.

出版信息

Br J Surg. 2024 Aug 2;111(8). doi: 10.1093/bjs/znae185.

Abstract

BACKGROUND

Women with thoracic aortic aneurysms within the arch or descending thoracic aorta have poorer survival than men. Sex differences in relative thoracic aortic aneurysm size may account for some of the discrepancy. The aim of this study was to explore whether basing clinical management on aneurysm size index (maximum aneurysm diameter/body surface area) rather than aneurysm size can restore equality of survival by sex.

METHODS

The Effective Treatments for Thoracic Aortic Aneurysms (ETTAA; ISRCTN04044627) study was a prospective, observational cohort study. Adults referred to National Health Service hospitals in England with new/existing arch or descending thoracic aorta aneurysms greater than or equal to 4 cm in diameter were followed from March 2014 to March 2022. Baseline characteristics and survival to intervention and overall were compared for men and women. Survival models were used to assess the association between all-cause survival and sex, with and without adjustment for aneurysm diameter or aneurysm size index.

RESULTS

A total of 886 thoracic aortic aneurysm patients were recruited: 321 (36.2%) women and 565 (63.8%) men. The mean(s.d.) aneurysm diameter was the same for women and men (5.7(1.1) versus 5.7(1.2) cm respectively; P = 0.751), but the mean(s.d.) aneurysm size index was greater for women than for men (3.32(0.80) versus 2.83(0.63) respectively; P < 0.001). Women had significantly worse survival without intervention: 110 (34.3%) women and 135 (23.9%) men (log rank test, P < 0.001). All-cause mortality remained greater for women after adjustment for diameter (HR 1.65 (95% c.i. 1.35 to 2.02); P < 0.001), but was attenuated after adjustment for aneurysm size index (HR 1.11 (95% c.i. 0.89 to 1.38); P = 0.359). Similar results were found for all follow-up, with or without intervention, and findings were consistent for descending thoracic aorta aneurysms alone.

CONCLUSION

Guidelines for referral to specialist services should consider including aneurysm size index rather than diameter to reduce inequity due to patient sex.

摘要

背景

胸主动脉弓部或降主动脉内的女性胸主动脉瘤患者的生存率低于男性。胸主动脉瘤相对大小的性别差异可能是导致这种差异的部分原因。本研究旨在探讨基于瘤体大小指数(最大瘤体直径/体表面积)而非瘤体大小进行临床管理是否可以通过性别恢复生存平等。

方法

有效治疗胸主动脉瘤(ETTAA;ISRCTN04044627)研究是一项前瞻性、观察性队列研究。2014 年 3 月至 2022 年 3 月,英格兰国民保健服务医院收治的新/现有胸主动脉弓部或降主动脉瘤直径大于或等于 4 厘米的成年患者入组该研究。比较男性和女性的基线特征和干预及总体生存率。使用生存模型评估全因生存率与性别之间的关系,同时调整和不调整瘤体直径或瘤体大小指数。

结果

共纳入 886 例胸主动脉瘤患者:女性 321 例(36.2%),男性 565 例(63.8%)。女性和男性的平均(标准差)瘤体直径相同(分别为 5.7(1.1)cm 和 5.7(1.2)cm;P = 0.751),但女性的平均(标准差)瘤体大小指数大于男性(分别为 3.32(0.80)和 2.83(0.63);P < 0.001)。未经干预的女性生存率显著较差:110 例(34.3%)女性和 135 例(23.9%)男性(对数秩检验,P < 0.001)。在调整直径后,女性的全因死亡率仍然更高(HR 1.65(95%置信区间 1.35 至 2.02);P < 0.001),但在调整瘤体大小指数后,该比值降低(HR 1.11(95%置信区间 0.89 至 1.38);P = 0.359)。在有无干预的情况下,所有随访结果均相似,且仅在降主动脉瘤中也观察到了类似结果。

结论

转诊至专科服务的指南应考虑纳入瘤体大小指数而非直径,以减少因患者性别而导致的不平等。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a27f/11293951/d5072432f8f6/znae185f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验